Eculizumab treatment for renal failure in a pediatric patient with COVID-19

Ruchi Mahajan, Marissa Lipton, Larisa Broglie, Namrata Gargee Jain, Natalie Somera Uy

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Abstract

While there are increasing reports of acute kidney injury among hospitalized adults with COVID-19, there is still limited information on renal complications associated with COVID-19 in children. The cause of kidney involvement in COVID-19 is likely multifactorial, and appears to involve a complex process, including complement dysregulation and thrombotic microangiopathy. We present a pediatric case of COVID-19 and renal failure due to thombotic microangiopathy, successfully treated with eculizumab.

Original languageEnglish (US)
Pages (from-to)1373-1376
Number of pages4
JournalJournal of Nephrology
Volume33
Issue number6
DOIs
StatePublished - Dec 2020
Externally publishedYes

Bibliographical note

Publisher Copyright:
© 2020, Italian Society of Nephrology.

Fingerprint

Dive into the research topics of 'Eculizumab treatment for renal failure in a pediatric patient with COVID-19'. Together they form a unique fingerprint.

Cite this